pharmaphorum speaks with Steven Davis of AstraZeneca on how the first year of its first direct-to-patient program - ARIMIDEX Direct has been. A year ago, AstraZeneca announced its first direct-to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback